Ambiq Micro Earnings Call Transcripts
Fiscal Year 2026
-
Q3 sales rose 110% YoY, with broad-based growth and improving gross margin. Q4 and FY26 guidance signal continued acceleration, while supply constraints and higher costs remain key execution risks.
-
Edge AI demand drove 90% year-over-year net sales growth and five straight quarters of sequential gains. Despite industry-wide supply constraints, guidance was raised to $135 million in full-year sales, with new products and markets fueling diversification. Gross margin improved to 47.2%.
-
Q1 2026 saw 59% year-over-year sales growth, driven by strong Edge AI demand and diversification beyond wearables. Guidance calls for continued high growth, with profitability targeted as revenue scales and investments in new products and markets accelerate.
Fiscal Year 2025
-
Record Q4 and full-year results driven by Edge AI adoption, with strong growth expected in 2026 across wearables and expanding non-wearable markets. Gross margin reached 45.5% in Q4, and guidance points to over $100 million in 2026 revenue.
-
Strong growth in edge AI and ultra-low-power chips is driving expansion into new markets, with a diversified customer base and new AI-first products like Atomic set to launch. Margins are stabilizing, funding is secure, and licensing opportunities are being pursued, while China exposure is capped for risk management.
-
Q3 2025 saw strong gross margin and improved net loss, driven by a strategic pivot to high-value edge AI markets and robust Apollo 5 adoption. Q4 guidance exceeds consensus, with continued revenue growth and margin expansion expected into 2026 and beyond.
-
Q2 2025 saw sequential revenue and gross profit growth, driven by a strategic shift away from China and strong adoption in wearables and non-wearables. The company completed its IPO, raising $97.2M to fund expansion, R&D, and IP licensing, with a positive outlook for the second half of 2025.